LAWSON BYRON (SVP/Chief Commercial Officer) received a stock award from HTG MOLECULAR DIAGNOSTICS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/13/2022ACC: 0001209191-22-061009
Officer· SVP/Chief Commercial Officer
Since Jan 2020
+1K
Net shares
Net buyer
$425.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1K
Price / share
$0.42
Trade value
$425.00
% of position
19.9%
12/9/2022
5.03K→6.03K
Total
Net shares
+1K
Net value
$425.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2022 | A · Award | +1K | $0.42 | $425.00 | 19.9% | 5.03K | 6.03K |
| Total | +1K | $425.00 | ||||||
Derivative Transactions0
No derivative transactions reported